Search Results - "Fleury, Justine"
-
1
Abstract 3904: PEP-010, a cell penetrating & interfering peptide as a new therapeutic approach in breast cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction. The interaction between intracellular caspase-9 and PP2A proteins is critical to apoptosis. We designed PEP-010, a Cell Penetrating &…”
Get full text
Journal Article -
2
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers
Published in Clinical cancer research (01-06-2018)“…Triple-negative breast cancer (TNBC) patients with residual disease after neoadjuvant chemotherapy have a poor outcome. We developed patient-derived xenografts…”
Get full text
Journal Article -
3
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Published in Oncotarget (24-04-2018)“…The prognosis of metastatic uveal melanoma (UM) is among the worst of all human cancers. The identification of near-ubiquitous GNAQ/GNA11 mutations and the…”
Get full text
Journal Article -
4
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
Published in Cancers (29-05-2019)“…Uveal melanoma (UM) remains without effective therapy at the metastatic stage, which is associated with (BRCA1 associated protein) mutations. However, no data…”
Get full text
Journal Article -
5
Abstract 5782: Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Purpose: The prognosis of metastatic uveal melanoma (UM) patients remains one of the worst observed in human cancers. The identification of frequently…”
Get full text
Journal Article -
6
Capecitabine efficacy is correlated with TYMP and RB expression in PDX established from triple-negative breast cancers
Published 2018“…PURPOSE: triple-negative breast cancer (TNBC) patients with residual disease after neoadjuvant chemotherapy have a poor outcome. We developed patient-derived…”
Get full text
Web Resource